These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 30071310

  • 1. Glutathione-responsive self-delivery nanoparticles assembled by curcumin dimer for enhanced intracellular drug delivery.
    Zhang H, Zhang Y, Chen Y, Zhang Y, Wang Y, Zhang Y, Song L, Jiang B, Su G, Li Y, Hou Z.
    Int J Pharm; 2018 Oct 05; 549(1-2):230-238. PubMed ID: 30071310
    [Abstract] [Full Text] [Related]

  • 2. Glutathione-sensitive PEGylated curcumin prodrug nanomicelles: Preparation, characterization, cellular uptake and bioavailability evaluation.
    Zhang HY, Sun CY, Adu-Frimpong M, Yu JN, Xu XM.
    Int J Pharm; 2019 Jan 30; 555():270-279. PubMed ID: 30471374
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: in vitro and in vivo evaluation.
    Hong J, Liu Y, Xiao Y, Yang X, Su W, Zhang M, Liao Y, Kuang H, Wang X.
    Drug Deliv; 2017 Nov 30; 24(1):109-120. PubMed ID: 28155567
    [Abstract] [Full Text] [Related]

  • 7. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
    Hong W, Guo F, Yu N, Ying S, Lou B, Wu J, Gao Y, Ji X, Wang H, Li A, Wang G, Yang G.
    Drug Des Devel Ther; 2021 Nov 30; 15():2843-2855. PubMed ID: 34234415
    [Abstract] [Full Text] [Related]

  • 8. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M, Teng L, Wang Y, Zhang J, Sun X.
    Drug Deliv; 2016 May 30; 23(4):1420-5. PubMed ID: 26203688
    [Abstract] [Full Text] [Related]

  • 9. Redox responsive xylan-SS-curcumin prodrug nanoparticles for dual drug delivery in cancer therapy.
    Sauraj, Vinay Kumar, Kumar B, Priyadarshi R, Deeba F, Kulshreshtha A, Kumar A, Agrawal G, Gopinath P, Negi YS.
    Mater Sci Eng C Mater Biol Appl; 2020 Feb 30; 107():110356. PubMed ID: 31761247
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Poly(D,L-lactic acid)-glycerol-based nanoparticles for curcumin delivery.
    Yoon IS, Park JH, Kang HJ, Choe JH, Goh MS, Kim DD, Cho HJ.
    Int J Pharm; 2015 Jul 05; 488(1-2):70-7. PubMed ID: 25900098
    [Abstract] [Full Text] [Related]

  • 15. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
    Guo F, Fu Q, Jin C, Ji X, Yan Q, Yang Q, Wu D, Gao Y, Hong W, Li A, Yang G.
    Drug Deliv; 2019 Dec 05; 26(1):1027-1038. PubMed ID: 31691601
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
    Sun L, Liu Z, Wang L, Cun D, Tong HHY, Yan R, Chen X, Wang R, Zheng Y.
    J Control Release; 2017 May 28; 254():44-54. PubMed ID: 28344018
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.